Syrma Johari MedTech Limited (SJML), a leading medical device design and manufacturing partner, successfully attended and exhibited at DeviceTalks Boston 2026, held from May 27–28, 2026, at the Boston Convention and Exhibition Center, United States.
DeviceTalks Boston is one of the East Coast’s premier gatherings for the medical device industry, bringing together MedTech innovators, OEMs, engineers, investors, product leaders, manufacturing experts, and regulatory professionals for focused discussions on product design, manufacturing, company building, financing, and commercialization.
Our exhibit at Booth 714 reflected SJML’s integrated, end-to-end MedTech capabilities – from innovation, product design, prototyping, and engineering to regulatory readiness, precision manufacturing, and lifecycle support. The event provided an excellent platform to showcase how SJML enables MedTech companies to move from concept to scalable commercialization through one connected, lifecycle-driven model.
On May 27, SJML presented an Engineering Theatre session titled “IMPACT – Integrated Model for Product Advancement, Compliance & Transfer.” We presented with one of our partners – bringing both the product owner perspective and the lifecycle partner execution lens, with real insights on what worked, what didn’t, and how ideas progressed seamlessly to scalable products. Every breakthrough medical device carries two stories:
1. The vision behind the product.
2. And the execution required to make it real.
At DeviceTalks Boston, Syrma Johari MedTech and Baebies came together to share both sides of that journey – from innovation and engineering decisions to manufacturing readiness and real-world scale. This wasn’t a theoretical discussion. It was a practical look at what it truly takes to move complex devices beyond prototypes.
Throughout DeviceTalks Boston 2026, our booth became a hub for meaningful conversations with global MedTech innovators, OEMs, startups, and industry leaders. Discussions focused on complex medical device development, AI in regulated workflows, product engineering, regulatory readiness, manufacturing scale-up, and lifecycle management. These interactions reinforced the industry’s growing need for integrated partnerships, execution excellence, and collaboration to bring safer, smarter, and more connected medical devices to market. As a trusted end-to-end MedTech partner, SJML remains committed to helping global companies design, manufacture, and commercialize high-quality medical devices with confidence.
